CORRELATIONS BETWEEN CLINICAL SEVERITY OF PULMONARY TUBERCULOSIS, THYROID FUNCTION AND SOME CYTOKINES
DOI:
https://doi.org/10.52692/1857-0011.2022.3-74.24Keywords:
pulmonary tuberculosis, thyroid, immunity, cytokinesAbstract
To estimate the interrelations between thyroid profile, some cytokines and clinical severity of new case of cavitary pulmonary tuberculosis 43 patients with cavitary pulmonary tuberculosis and 10 healthy volunteers were studied. Thyroid glands of all patients before chemotherapy and volunteers from control group were examined by ultrasound. The levels of free thyroxine, thyroid stimulating hormone and antibodies to thyroglobulin and thyroid peroxidase in the serum were defined. At the same time the levels of tumor necrosis tumor necrosis factor, interferon-gamma and interleukin-2, -6, and-4 were measured. Correlations between clinical severity of new case of pulmonary tuberculosis, thyroid functions, and these cytokines were studied. The pathological changes of thyroid echo structures were recovered in more than half of patients. The level of thyroxine in tuberculous patients was decreased down to lower-normal significance. In tuberculous patients with pathological echo structure of the thyroid the thyroxine level decreasing was more significant. The thyroxine stimulating hormone level was increased in these patients. The increasing of tumor necrosis tumor factor and the interleukin-6 levels and the decreasing of interleukin-4 level were demonstrated in tuberculous patients comparing with healthy persons. Positive correlation between clinical severity of new case of pulmonary tuberculosis, thyroid functions, and these cytokines were determined. The high percentage defined cases of thyroid pathology in tuberculous patients is caused the necessity the screening of thyroid function in tuberculous patients for in time diagnosis of its subclinical disorders and their correction to restore cytokines balance and improving of antituberculosis chemotherapy efficacy.
References
Biondi B, Cooper D.S. The clinical significance of subclinical thyroid dysfunction. Endocrine Review, 2008; 29 (1): 76-131.
Brabant G, Beck-Peccoz P, Jarzab B et al. Is there a need to redefine the upper normal limit of TSH? Eur. J. of Endocrinol., 2006; 154: 633-7.
Cavalcanti YVN Role of TNF-alpha, IFN-gamma and L-10 in the development of pulmonary tuberculosis. Pul. Med., 2012:745493.
De Groot L, Quintans J. The causes of autoimmune thyroiditis (Hashimoto disease). Endocr. Rev., 1989; 10: 537-62.
Frick LR, Rapanelli M, Bussman UA Kleche A.J. et al. Involvement of thyroid hormones in the alterations of T-cell immunity and tumour progression. Biol. Psychiatry, 2009; 65 (11): 935-42.
Hamilton TE, Davis S, Onstad L, Rjpecky KJ Thyrotropin levels in a population with no with no clinical, autoantibody, or ultrasound evidence of thyroid disease; implications for the diagnosis of subclinical hypothyroidism, J.Clin. Endocrinol. Metabol., 2002; 87: 489-99.
Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T4 and thyroid antibodies in the United States population (1988-1994): National Health and Nutrition Examination (NHANES 111), J.Clin. Endocrinol. Metabol., 2002; 87: 489-99.
Gharib H, Turtle RM, Baskin HL et al. Subclinical thyroid dysfunctions: a joint statement on management from the American Association of Clinical Endocrinologists. The American Thyroid Association and Endocrine Society. J. Clin. Endocrinol. Metabol., 2005; 90 (1): P.581-85.
Hodkinson CF, Simpson EEA, Beattie JH et al. Preliminary evidence of immune function modulation by thyroid hormones in healthy men and women aged 55-77 years. J. Endocrinol., 2009; 202: 55-63.
Howlett DC Sonographic assessment of the thyroid gland – a Pictorial Review. Ultrasound, 2008; 16: 36-42.
Ladel CH, Blum C, Dreher A et al Lethal tuberculosis in interleukin-6 deficient mutant mice. Infect. Immun.,1997; 65: 4843-9.
Lin HY, Thacore H, Davies FB et al. Thyroid hormone analogues potentiate the interferon-gamma by two mechanisms. J. Cell Physiol., 1996; 167 (2): 269-76.
Lin HY, Thacore H, Davies FB, Mortino IJ et al Potentiation by thyroxine of interferon-gamma-induced HLA-DR expression is protein kinase Aand C-dependent.J. Interferon Cytokine Res.,1996; 16 (1): 17-24.
Mahuad C, Bozza V, Pezzotto SM, Bay ML, Besedovsky H, del Rey A, Botasso O Impaired immune responses in tuberculosis patients are related to weight loss that coexists with immunoendocrine imbalance. Clin. Exp. Immunol., 2007; 14 (3-4): 193-9.
McIver B, Gorman CA Euthyroid sick syndrome: an overview. Thyroid, 1997; V.7: 125-32.
Nagaya T, Fujieda M, Otsuka G, et al. A potential role of activated NF-kappa [beta] in the pathogenesis of euthyroid sick syndrome. J. Clin. Invest., 2000; 106: 393-2.
Papanas N, Papatheodorou K, Papazoglou B et al. Post-thyroidectomy thyroxine replacement dose in patients with or without compensated heart failure. Cytokine, 2008; 41(2): 121-6.
Paterman HG, Jamnitski A, Lems WF et al Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 monthes of adalimumab treatment: a pilot study. J. Rheumatology, 2010: http://www. jrheum.org/content/early/2010/12/ jrheum.100488
Reinfenberg K, Kopf M, Kaufmann SH Lethal tuberculosis in interleukin-6-deficient mice. Infect. Immun.,1997; 65: 4843-9.
Shiratsuchi H, Johnson JL, Ellner JJ Bidirections effects of cytokines on the growth of M. avium within human monocytes. J.Immunol., 1991; 146: 3165-70.
Stouthard JM., van der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J. Clin. Endocrinol. Metab.,1994; 79: 1342-46.
Tominaga T, Yamashita S, Nagayama Y, et al. Interleukin-6 inhibits human thyroid peroxidase gene expression., Acta Endocrinol., 1991; 124: P.290-4.
Vallis RS, Ellner J Cytokines and tuberculosis. J. Leuk. Biol.; 1994: 55: .676-81.
Van der Poll T, Romijn JA, Wiersinga WM, et al Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J. Clin. Endocrinol. Metab., 1990; 71: 1567-72.
Van Snick J Interleukin 6; an overview. Ann. Rev. Immunol.; 1990: 8: 253-78.
Verbon, Suffermans N, Van Deventer SJH, Van Der Poll T Serum concentration of cytokines in patients with active tuberculosis (TB) and after treatment. Clin. Exp. Immunol, 1999; 115: 110-13.
Vivecanadan MM, Adancuvan E, Anicegyei W et al Plasma cytokines characterize disease pathogenesis and treatment in tuberculosis patients. Springer Link. Infection, 2022: 798.
Waise A, Price HC The upper limit of the reference range for thyroid-stimulating hormone should not be confused with a cut-off to define subclinical hypothyroidism. Ann. Clin. Biochemistry, 2009; 46: 93-8.
Wilson GR, Curry PWJ Subclinical thyroid disease. Am. Fam. Physician, 2005; 72 (8):1517-24.
Zophel K, Wunderlich G, Kozerke J Should we really determine a reference population for the definition of thyroid-stimulating hormone reference interval? Clin. Chemistry, 2006; 52: 329-30.
Zosin I The Importance of Screening of Thyroid Dysfunctions. International Endocrinological Journal. – 2009. – Т.19, № 1. – P.33-45.
Xing D, Liu D, Xu Y Factors influencing the reference increase of thyroid stimulating hormone in healthy adults: A systematic review and meta-analysis. Clin. Endocrinol. (Oxf). – 2021: 95(3): 378-389.
Downloads
Published
License
Copyright (c) 2022 Bulletin of the Academy of Sciences of Moldova. Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
